BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sun YL, Shang LR, Liu RH, Li XY, Zhang SH, Ren YK, Fu K, Cheng HB, Yahaya BH, Liu YL, Lin JT. Therapeutic effects of menstrual blood-derived endometrial stem cells on mouse models of streptozotocin-induced type 1 diabetes. World J Stem Cells 2022; 14(1): 104-116 [PMID: 35126831 DOI: 10.4252/wjsc.v14.i1.104]
URL: https://www.wjgnet.com/1948-0210/full/v14/i1/104.htm
Number Citing Articles
1
Maleesha Jayasinghe , Omesh Prathiraja, Prashan B Perera, Rahul Jena, Minollie Suzanne Silva, P.S.H. Weerawarna, Malay Singhal, Abdul Mueez Alam Kayani, Snigdha Karnakoti, Samiksha Jain. The Role of Mesenchymal Stem Cells in the Treatment of Type 1 Diabetes Cureus 2022;  doi: 10.7759/cureus.27337
2
Yunfei Luo, Peng Yu, Jianping Liu. The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: Recent advances and current challengesEndocrine 2024;  doi: 10.1007/s12020-024-03855-8
3
Jingpeng Hao, Ai Ma, Chenglu Sun, Hong Qin, Yanglin Zhu, Guangming Li, Hongda Wang, Hao Wang. Melatonin pretreatment improves endometrial regenerative cell-mediated therapeutic effects in experimental colitisInternational Immunopharmacology 2024; 133: 112092 doi: 10.1016/j.intimp.2024.112092
4
Wei Zhang, Qing Ling, Bin Wang, Kai Wang, Jianbo Pang, Jing Lu, Yan Bi, Dalong Zhu. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetesStem Cell Research & Therapy 2022; 13(1) doi: 10.1186/s13287-022-02974-1